Biological information analysis device, biological information processing method, and biological information program
The biological information processing device accurately separates and displays CMAP waveforms from electrocardiogram interference, ensuring precise diaphragm monitoring and reducing nerve damage risks during medical procedures.
Patent Information
- Application Number
- JP2023070888
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-04-24
- Publication Date
- 2024-11-06
AI Technical Summary
The electrocardiogram waveform often mixes with compound muscle action potential (CMAP) measurements, making it difficult to accurately monitor the condition of the diaphragm during procedures like ablation, which can lead to nerve damage.
A biological information processing device that receives and displays CMAP waveforms, identifies periods of potential electrocardiogram interference, and provides clear visual notifications to distinguish between the two, allowing for accurate monitoring of diaphragm condition.
Enables precise monitoring of diaphragm condition by distinguishing CMAP from electrocardiogram interference, thereby reducing the risk of nerve damage during medical procedures.
Smart Images

Figure 2024156433000001_ABST
Abstract
Description
[Technical field]
[0001] The present disclosure relates to a biological information analysis device, a biological information processing method, and a biological information program.
[0002] Conventionally, phrenic nerve damage may occur as a complication when ablation is performed on a subject, and it is known that measuring compound motor action potential (CMAP) is effective in preventing this. Patent Document 1 discloses a method for evaluating the function of the diaphragm of a human or animal by applying electrical or magnetic stimulation to the diaphragm and measuring the response of the diaphragm to the stimulation. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] Special Publication No. 2022-500147 Summary of the Invention [Problem to be solved by the invention]
[0004] However, there are cases where the subject's electrocardiogram waveform is mixed into the CMAP measurement results, and in such cases, it may be difficult to accurately monitor the state of the subject's diaphragm.
[0005] The present disclosure provides a biological information analysis device, a biological information processing method, and a biological information program capable of more accurately monitoring the state of a subject's diaphragm. [Means for solving the problem]
[0006] A biological information processing device according to an embodiment of the present disclosure includes: A receiving unit that receives a measurement result of a compound muscle action potential of a subject to which a diaphragm is stimulated; a display processing unit that displays a waveform showing a time series change of the compound muscle action potential on a screen based on the measurement result; A determination unit that determines a period during which the waveform may be contaminated by the electrocardiogram waveform of the subject, The display processing unit causes the period determined by the determination unit to be recognizably displayed on the screen.
[0007] A biological information processing method according to an embodiment of the present disclosure includes: A method for a biometric information processing device, comprising: receiving measurements of a compound muscle action potential of a subject receiving stimulation of the diaphragm; displaying on a screen a waveform showing a time series change of the compound muscle action potential based on the measurement result; determining a period during which the waveform may be contaminated by the subject's electrocardiogram waveform; and causing the period to be recognizably displayed on the screen.
[0008] A biological information processing program according to an embodiment of the present disclosure includes: A program for use in a biometric information processing device, receiving measurements of a compound muscle action potential of a subject receiving stimulation of the diaphragm; displaying on a screen a waveform showing a time series change of the compound muscle action potential based on the measurement result; determining a period during which the waveform may be contaminated by the subject's electrocardiogram waveform; and a step of displaying the period on the screen in a recognizable manner. Effect of the Invention
[0009] According to the present disclosure, the condition of the subject's diaphragm can be monitored more accurately. [Brief description of the drawings]
[0010] [Figure 1]FIG. 1 is a diagram illustrating a configuration of a biological information processing system according to an embodiment of the present disclosure. [Diagram 2] FIG. 2 is a diagram illustrating a configuration of the biometric information processing apparatus illustrated in FIG. [Diagram 3] FIG. 3 is a diagram showing an example of a screen displayed by the biometric information processing apparatus shown in FIG. [Figure 4] FIG. 4 is a diagram for explaining a CMAP waveform that is displayed upside down by the display processing unit shown in FIG. [Diagram 5] FIG. 5 is a diagram showing an example of a state in which an electrocardiogram waveform measured using the surface electrocardiogram measurement electrodes is mixed into a CMAP waveform measured using the CMAP measurement electrodes shown in FIG. [Figure 6] FIG. 6 is a diagram showing another example of a state in which an electrocardiogram waveform measured using the surface electrocardiogram measurement electrodes is mixed into a CMAP waveform measured using the CMAP measurement electrodes shown in FIG. [Figure 7] FIG. 7 is a diagram illustrating an example of a contamination notification process performed by the display processing unit illustrated in FIG. [Figure 8] FIG. 8 is a flowchart for explaining a process flow when the biological information processing device according to the embodiment of the present disclosure analyzes the CMAP of a subject using the biological information processing method. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, an embodiment of a biometric information processing device, a biometric information processing method, and a biometric information program according to the present invention will be described with reference to the accompanying drawings.
[0012] [Biometric information processing system configuration] 1 is a diagram showing a configuration of a biological information processing system 100 according to an embodiment of the present disclosure. The biological information processing system 100 includes a biological information processing device 10, a diagnostic stimulation device 11, an amplifier 12, a connection device 13, and an ablator 14. By using the biological information processing system 100, an operator can perform ablation on a subject X, measure the surface electrocardiogram of the subject X, and measure the CMAP of the subject X.
[0013] (Ablation) When performing ablation on subject X, the operator inserts the ablation catheter 16 into the heart of subject X. Then, the operator operates the ablation catheter 14 to apply high-frequency current to an abnormal part or the like that is the source of arrhythmia of subject X via the ablation catheter 16, thereby ablatating the part.
[0014] (Surface electrocardiogram measurement) In parallel with the ablation, the operator measures the surface electrocardiogram of the subject X using the surface electrocardiogram measurement electrodes 18 attached to the body surface of the subject X. More specifically, the surface electrocardiogram measurement electrodes 18 obtain electrical signals from each part of the heart and transmit them to the bioinformation processing device 10. The bioinformation processing device 10 records the state of each part of the heart of the subject X based on the electrical signals transmitted from the surface electrocardiogram measurement electrodes 18.
[0015] (CMAP measurement) In addition, the operator monitors the compound motor action potential (CMAP) of the subject X in order to prevent phrenic nerve damage that may occur in the subject X as a complication of the ablation. Specifically, the operator inserts a stimulation catheter 15 into the body of the subject X and operates a diagnostic stimulation device 11 to apply electrical stimulation to the phrenic nerve of the subject X one or more times via an amplifier 12.
[0016] In addition, the diagnostic stimulation device 11 is connected to the bio-information processing device 10, and transmits timing information indicating the timing ta (see FIG. 3) of applying a stimulus to the phrenic nerve of the subject X, for example, to the bio-information processing device 10.
[0017] CMAP measurement electrodes 17 are attached to the body surface of the subject X. When the phrenic nerve of the subject X is electrically stimulated, a signal indicating the response of the phrenic nerve to the stimulation, i.e., the CMAP, is transmitted via the CMAP measurement electrodes 17 to the amplifier 12 via the connection device 13. The amplifier 12 amplifies the electrical signal from the CMAP measurement electrodes 17 and transmits it to the bioinformation processing device 10.
[0018] The bio-information processing device 10 generates a CMAP waveform indicating a time series change of the CMAP of the subject X based on the signal transmitted from the CMAP measurement electrode 17. Then, the bio-information processing device 10 displays the generated CMAP waveform on a screen such as a monitor. The bio-information processing device 10 will be described in detail below.
[0019] [Configuration of the biometric information processing device 10] Fig. 2 is a diagram showing a configuration of the biometric information processing device 10 shown in Fig. 1. Fig. 3 is a diagram showing an example of a screen displayed by the biometric information processing device 10 shown in Fig. 2. With reference to Figs. 2 and 3, the biometric information processing device 10 includes an information processing unit 21, a receiving unit 22, a storage unit 23, and a display processing unit 24. The information processing unit 21 has a determination unit 31 and an analysis unit 32.
[0020] (Displays surface ECG, CMAP waveform and stimulation timing) The storage unit 23 may have a biometric information processing program, which is an operation program used by the biometric information processing device 10, installed therein.
[0021] The receiving unit 22 receives the electrical signal transmitted from the CMAP measurement electrodes 17 via the connection device 13 and the amplifier 12, and outputs the electrical signal to the information processing unit 21. The receiving unit 22 also receives the electrical signal transmitted from the surface ECG measurement electrodes 18, and outputs the electrical signal to the information processing unit 21.
[0022] The analysis unit 32 in the information processing unit 21 generates an electrocardiogram waveform indicating the state of each part of the heart of the subject X based on the electrical signal from the surface electrocardiogram measurement electrodes 18, and outputs data indicating the electrocardiogram waveform to the display processing unit 24. When the display processing unit 24 receives the data indicating the electrocardiogram waveform, it performs processing to display the electrocardiogram waveform of the subject X on a screen based on the data, as shown in Fig. 3.
[0023] Furthermore, the receiving unit 22 receives timing information transmitted from the diagnostic stimulation device 11, and outputs the received timing information to the information processing unit 21. The analysis unit 32 in the information processing unit 21 identifies the timing ta of applying each stimulus to the phrenic nerve of the subject X based on the timing information from the diagnostic stimulation device 11, and notifies the display processing unit 24 of the identified application timing ta. When the display processing unit 24 receives the notification of each application timing ta from the analysis unit 32, it performs a process of displaying each application timing ta on the screen. In the example shown in Fig. 3, application timings ta1, ta2, and ta3 are displayed as the application timing ta for each stimulus.
[0024] Furthermore, the receiving unit 22 receives a signal transmitted from the CMAP measurement electrodes 17, and outputs the signal to the information processing unit 21. The analyzing unit 32 in the information processing unit 21 generates a CMAP waveform based on the signal from the CMAP measurement electrodes 17, and outputs data indicating the generated CMAP waveform to the display processing unit 24. The display processing unit 24 performs processing to display a CMAP waveform as shown in Fig. 3 on a screen based on the data indicating the CMAP waveform.
[0025] Here, when displaying the CMAP waveform, the display processor 24 can display the CMAP waveform upside down on the screen. Fig. 4 is a diagram for explaining the CMAP waveform displayed upside down by the display processor 24 shown in Fig. 2. For example, the operator can arbitrarily set the order of the waveform trough wa and the waveform peak wb in the CMAP waveform by setting the bio-information processing device 10 in advance.
[0026] Specifically, a waveform pattern in which a waveform trough wa is followed by a waveform crest wb is defined as "Pattern A." Also, a waveform pattern in which a waveform crest wb is followed by a waveform trough wa is defined as "Pattern B."
[0027] It is assumed that the operator has previously set the bio-information processing device 10 to display the CMAP waveform in "Pattern B."
[0028] In this case, when the data indicating the CMAP waveform received from the analysis unit 32 indicates a waveform of pattern A, the display processing unit 24 displays the waveform on the screen by inverting the waveform vertically so that the waveform becomes a waveform of pattern B, according to the settings made by the operator. When the data indicating the CMAP waveform received from the analysis unit 32 indicates a waveform of pattern B, the display processing unit 24 displays the waveform on the screen as it is, without inverting the waveform, as the waveform of pattern B.
[0029] Also, assume that the operator has previously set the biological information processing device 10 to display the CMAP waveform in "Pattern A."
[0030] In this case, when the data indicating the CMAP waveform received from the analysis unit 32 indicates a waveform of pattern B, the display processing unit 24 displays the waveform on the screen by inverting the waveform vertically so that the waveform becomes a waveform of pattern A, according to the settings made by the operator. Also, when the data indicating the CMAP waveform received from the analysis unit 32 indicates a waveform of pattern A, the display processing unit 24 displays the waveform on the screen as it is, without inverting the waveform.
[0031] By performing this type of inversion process, for example, if an operator feels uncomfortable with the order of the peaks wb and valleys wa in the CMAP waveform, the waveform can be displayed inverted vertically according to the operator's settings, thereby eliminating the sense of discomfort.
[0032] (CMAP analysis and warning processing) The analysis unit 32 performs an analysis of the CMAP every time a stimulus is input to the phrenic nerve of the subject X. More specifically, for example, as shown in Fig. 3, the storage unit 23 stores a first time Tx, which is the length from the timing ta of applying a stimulus to the phrenic nerve to the start timing of a period AT to be analyzed for the measurement result of the CMAP (hereinafter, referred to as the "analysis target period"), and a second time Ty, which is the length of the analysis target period AT.
[0033] The analysis unit 32 sets an analysis period AT for each stimulus input using the first time Tx and the second time Ty stored in the memory unit 23, and the timing ta of each stimulus application identified based on the timing information from the diagnostic stimulation device 11.
[0034] The storage unit 23 also stores a reference value Ds used in the analysis of the CMAP. The reference value Ds is, for example, the difference between the minimum and maximum values of the CMAP waveform of the subject X in a normal state in which no ablation is being performed in the heart of the subject X.
[0035] The analysis unit 32 calculates the difference D between the minimum and maximum values of the CMAP waveform for each analysis period AT that has been set. The analysis unit 32 then calculates the ratio R of the difference D to the reference value Ds stored in the storage unit 23, and notifies the display processing unit 24 of the calculated ratio R. The display processing unit 24 performs processing to display the ratio R notified by the analysis unit 32 in a recognizable manner for each analysis period AT.
[0036] In the screen shown in FIG. 3, three analysis periods AT1, AT2, and AT3 are displayed as the analysis period AT. For example, the figure "97%" which is the ratio R in the analysis period AT1 is displayed together with a line M1 connecting the maximum and minimum values of CMAP. Also, for example, the figure "48%" which is the ratio R in the analysis period AT2 is displayed together with a line M2 connecting the maximum and minimum values of CMAP. Furthermore, for example, the figure "54%" which is the ratio R in the analysis period AT3 is displayed together with a line M3 connecting the maximum and minimum values of CMAP.
[0037] In this way, by displaying the ratio R for each stimulation of the phrenic nerve, the operator can easily compare the state of the diaphragm of the subject X in a normal state with the current state of the diaphragm of the subject X.
[0038] Furthermore, the analysis unit 32 judges whether the calculated ratio R is equal to or less than a threshold value. If the ratio R is equal to or less than the threshold value, the analysis unit 32 notifies the display processing unit 24 of the ratio R. In response to the notification from the analysis unit 32, the display processing unit 24 performs a warning process such as changing the display mode of a ratio R that is equal to or less than the threshold value and a ratio R that is greater than the threshold value.
[0039] Specifically, the threshold is assumed to be 70%. In the example shown in Fig. 3, the ratio R in the analysis period AT1 is 97%, the ratio R in the analysis period AT2 is 48%, and the ratio R in the analysis period AT3 is 54%. In this case, the display processing unit 24 displays the numerical value "97%" in a different background color from the numerical values "48%" and "54%" on the screen.
[0040] In this manner, by configuring the display processing unit 24 to change the display mode on the screen between a percentage R equal to or greater than the threshold value and a percentage R less than the threshold value, the operator can be clearly informed that the state of the diaphragm of the subject X is different from the normal state.
[0041] Furthermore, the display processing unit 24 displays the analysis results by the analysis unit 32 in a specific area E on the screen. For example, the display processing unit 24 displays the difference D between the minimum and maximum values of the CMAP waveform in the most recent analysis period AT, the reference value Ds, and the ratio R in the area E. In this manner, the configuration in which information related to CMAP is displayed collectively can reduce the burden on the operator monitoring the condition of the subject X.
[0042] The display processing unit 24 may display a notice on the screen to prompt the user to stop ablation as the warning process. Also, an output unit (not shown) in the bio-information processing device 10 may output a warning sound as the warning process.
[0043] (How to deal with the case where the ECG waveform is mixed into the CMAP waveform) Here, as described above, the CMAP is measured using the CMAP measurement electrodes 17 attached to the body surface of the subject X, and therefore the electrocardiogram waveform measured using the body surface electrocardiogram measurement electrodes 18 may be mixed into the CMAP waveform.
[0044] Fig. 5 is a diagram showing an example of a state in which an electrocardiogram waveform measured using the surface electrocardiogram measurement electrodes 18 is mixed into a CMAP waveform measured using the CMAP measurement electrodes 17 shown in Fig. 1. In Fig. 5, a CMAP waveform mixed with a QRS wave (hereinafter referred to as a "V wave") of an electrocardiogram is shown by a solid line G11, and a CMAP waveform not mixed with a V wave of an electrocardiogram is shown by a dashed line G12. In Fig. 5, when a V wave of an electrocardiogram is mixed into the CMAP waveform, the difference between the minimum value and the maximum value of the CMAP waveform is smaller than when a V wave of an electrocardiogram is not mixed.
[0045] Fig. 6 is a diagram showing another example of a state in which an electrocardiogram waveform measured using the surface electrocardiogram measurement electrodes 18 is mixed into a CMAP waveform measured using the CMAP measurement electrodes 17 shown in Fig. 1. In Fig. 6, a CMAP waveform mixed with a V wave of an electrocardiogram is shown by a solid line G21, and a CMAP waveform not mixed with a V wave of an electrocardiogram is shown by a dashed line G22, as in Fig. 5. In Fig. 6, when a V wave of an electrocardiogram is mixed into a CMAP waveform, the difference between the minimum and maximum values of the CMAP waveform is larger than when a V wave of an electrocardiogram is not mixed.
[0046] In this way, if the V wave of the electrocardiogram waveform is mixed into the CMAP waveform, it affects the difference between the minimum and maximum values of the CMAP waveform, which may make it difficult to accurately monitor the state of the diaphragm of the subject X. For this reason, the biological information processing device 10 according to the embodiment of the present disclosure performs the following process.
[0047] That is, the determination unit 31 in the biological information processing device 10 shown in Fig. 2 determines a period during which the V wave of the electrocardiogram waveform may have been mixed into the CMAP waveform. For example, the determination unit 31 identifies the rising timing of the V wave of the electrocardiogram waveform based on the electrical signal from the surface electrocardiogram measurement electrodes 18. Then, when the timing is included in the analysis period AT set by the analysis unit 32, the determination unit 31 determines that the V wave of the electrocardiogram waveform may have been mixed into the CMAP waveform during the analysis period AT. In this case, the determination unit 31 notifies the display processing unit 24 of the determination result.
[0048] When the display processing unit 24 receives from the judgment unit 31 the judgment result that the CMAP waveform may have been contaminated by a V wave of an electrocardiogram waveform during the analysis period AT, the display processing unit 24 performs a process of recognizably displaying the analysis period AT on the screen (hereinafter referred to as a "contamination notification process"). For example, the display processing unit 24 displays on the screen a symbol or character indicating that the CMAP waveform may have been contaminated by a V wave of an electrocardiogram waveform during the analysis period AT.
[0049] Fig. 7 is a diagram showing an example of a contamination notification process by the display processing unit 24 shown in Fig. 2. Specifically, when the display processing unit 24 receives the above notification, it displays, for example, the letter "V" in area E on the screen. By displaying in this manner, it is possible to notify the operator that a V wave of an electrocardiogram waveform may have been mixed into the CMAP waveform.
[0050] The contamination notification process by the display processing unit 24 is not limited to displaying the letter "V." For example, upon receiving a notification from the determination unit 31, the display processing unit 24 may extract a portion of the CMAP waveform that may be contaminated by an electrocardiogram waveform, i.e., a CMAP waveform included in the most recent analysis target period AT, and display the extracted portion in the area E. By performing such a process, the operator can clearly grasp the portion of the CMAP waveform that may be contaminated by an electrocardiogram waveform.
[0051] Furthermore, the display processing unit 24 may display the CMAP waveform included in the most recent analysis period AT in the area E, regardless of the presence or absence of a notification from the judgment unit 31. In this case, the display processing unit 24 may perform processing such as changing the background color of the CMAP waveform displayed in the area E between a state where a notification from the judgment unit 31 has not been received and a state where a notification from the judgment unit 31 has been received.
[0052] [Operation flow] 8 is a flowchart for explaining a process flow when the bio-information processing device 10 according to the embodiment of the present disclosure uses the bio-information processing method to analyze the CMAP of the subject X. With reference to Fig. 1 and Fig. 8, first, the bio-information processing device 10 receives timing information indicating the timing ta of applying a stimulus to the phrenic nerve of the subject X from the diagnostic stimulator 11 (step S11).
[0053] Next, the bio-information processing device 10 performs a process of recognizing and displaying the timing ta of each stimulation to the phrenic nerve of the subject X on the screen displaying the CMAP waveform based on the timing information received in step S11 (step S12).
[0054] Next, the biological information processing device 10 receives a signal indicating the CMAP measurement result from the CMAP measurement electrode 17 (step S13).
[0055] Next, the bio-information processing device 10 performs a process of displaying the CMAP waveform on the screen based on the signal. At this time, if the waveform pattern of the CMAP waveform is different from the waveform pattern preset by the operator, the bio-information processing device 10 performs a process of inverting the waveform pattern to display the CMAP waveform (step S14).
[0056] Next, the biological information processing device 10 sets an analysis period AT of the CMAP for each stimulation based on, for example, a first time Tx and a second time Ty that are preset (step S15).
[0057] Next, the biological information processing device 10 checks whether or not there is a possibility that a V wave of an electrocardiogram waveform is mixed into the CMAP waveform during the most recent analysis period AT (step S16).
[0058] For example, assume that the rising timing of the V wave of the electrocardiogram waveform is included in the analysis period AT, as in the analysis period AT3 shown in Fig. 7. In this case, the biological information processing device 10 determines that the V wave of the electrocardiogram waveform may have been mixed into the CMAP waveform in the analysis period AT ("YES" in step S16), and performs a mixing notification process, such as displaying the letter "V" in area E of the screen (step S17).
[0059] Next, the biological information processing device 10 calculates the difference D between the minimum and maximum values of the CMAP waveform for each analysis period AT (step S18), and calculates the ratio R of the difference to the reference value Ds (step S19).
[0060] Next, the bio-information processing device 10 judges whether the calculated ratio R is equal to or less than a threshold value (step S20). If the bio-information processing device 10 judges that the ratio R is equal to or less than the threshold value ("YES" in step S20), the bio-information processing device 10 performs a warning process (step S21) such as changing the background color of the value of the ratio R on the screen or displaying a notice on the screen to prompt the user to stop ablation.
[0061] On the other hand, when the biological information processing device 10 determines that the ratio R is greater than the threshold value ("NO" in step S20), it does not perform a warning process and continues the analysis of the CMAP.
[0062] Furthermore, in step S16, for example, if the rising timing of the V wave of the electrocardiogram waveform is not included in the analysis period AT, the bioinformation processing device 10 determines that the V wave of the electrocardiogram waveform is not mixed into the CMAP waveform in the analysis period AT ("NO" in step S16). In this case, the bioinformation processing device 10 performs the operations from step S18 onwards without performing the mixing notification process (step S17).
[0063] As described above, in the biological information processing device 10 according to one embodiment of the present disclosure, the receiving unit 22 receives the measurement result of the CMAP of the subject X, whose diaphragm is stimulated. The display processing unit 24 displays a CMAP waveform showing a time series change of the CMAP on the screen based on the measurement result. The determining unit 31 determines a period during which the electrocardiogram waveform of the subject X may be mixed into the CMAP waveform. The display processing unit 24 then displays the period determined by the determining unit 31 on the screen in a recognizable manner.
[0064] With this configuration, the operator can know whether the CMAP waveform currently displayed on the screen accurately represents the state of the diaphragm of the subject X, i.e., whether the reliability of the displayed CMAP waveform is high or not. Therefore, the state of the diaphragm of the subject X can be monitored more accurately.
[0065] Although the embodiment of the present disclosure has been described above, the technical scope of the present application should not be interpreted as being limited by the description of the present embodiment. The present embodiment is an example, and it is understood by those skilled in the art that various modifications of the embodiment are possible within the scope of the invention described in the claims. The technical scope of the present application should be determined based on the scope of the invention described in the claims and its equivalents. [Explanation of symbols]
[0066] 10: Biological information processing device, 11: Diagnostic stimulation device, 12: Amplifier, 13: Connection device, 14: Ablator, 15: Stimulation catheter, 16: Catheter for cauterization, 17: Electrode for CMAP measurement, 18: Electrode for surface electrocardiogram measurement, 21: Information processing unit, 22: Receiving unit, 23: Memory unit, 24: Display processing unit, 31: Judgment unit, 32: Analysis unit, 100: Biological information processing system
Claims
1. A receiving unit that receives a measurement result of a compound muscle action potential of a subject when a stimulus is applied to the diaphragm; a display processing unit that displays a waveform showing a time series change of the compound muscle action potential on a screen based on the measurement result; A determination unit that determines a period during which the waveform may be contaminated by the subject's electrocardiogram waveform, The display processing unit causes the period determined by the determination unit to be recognizably displayed on the screen.
2. The biological information processing device according to claim 1 , wherein the display processing unit causes a symbol or character indicating that an electrocardiogram waveform of the subject may be mixed into the waveform during the period on the screen.
3. The biometric information processing device further includes: An analysis unit that analyzes the measurement results, The biometric information processing apparatus according to claim 2 , wherein the display processing unit displays the analysis result by the analysis unit and the symbol or the character in a specific area on the screen.
4. The biological information processing apparatus according to claim 1 , wherein the display processing unit extracts a portion of the waveform that may possibly be contaminated by an electrocardiogram waveform of the subject, and displays the extracted portion on the screen.
5. The biological information processing apparatus according to claim 1 , wherein the display processing unit is capable of displaying the waveform on the screen by inverting the waveform vertically.
6. A biometric information processing method in a biometric information processing device, comprising: receiving measurements of a compound muscle action potential of a subject receiving stimulation of the diaphragm; displaying on a screen a waveform showing a time series change of the compound muscle action potential based on the measurement result; determining a period during which the waveform may be contaminated by the subject's electrocardiogram waveform; and displaying the period on the screen in a recognizable manner.
7. A biometric information processing program for use in a biometric information processing device, receiving measurements of a compound muscle action potential of a subject receiving stimulation of the diaphragm; displaying on a screen a waveform showing a time series change of the compound muscle action potential based on the measurement result; determining a period during which the waveform may be contaminated by the subject's electrocardiogram waveform; and displaying the period on the screen in a recognizable manner.
Citation Information
Patent Citations
Measuring signal amplifier and method for supplying energy to a measuring signal amplifier
JP2018510022A
Holter electrocardiogram recording device, medical system, and setting information sharing method in holter electrocardiogram recording device
JP2022104070A
Biological signal processing device, biological signal inspection device, and biological signal processing method
JP2022170027A
Monitoring diaphragmatic response to phrenic nerve stimulation
US20230026175A1
Methods, Instruments and Apparatus for Measuring Diaphragmatic Functional Parameters
JP2022500147A
